Insider Trading activities of Osiris Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Osiris Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Osiris Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Osiris Therapeutics, Inc. since 2005. The reporting company's ticker symbol is OSIR. The reporting company's CIK number is 1360886.
The total value of stock buying since 2005 is $33,527,691.
The total value of stock sales since 2005 is $4,169,278.
The total value of stock option exercises since 2005 is $13,074,220.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Osiris Therapeutics, Inc. (OSIR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-01 0 $0 0 $0 25,000 $128,400
2015-11 0 $0 0 $0 41,500 $276,820
2015-08 0 $0 2,425 $44,183 5,000 $2,000
2015-06 100 $1,882 0 $0 0 $0
2015-05 0 $0 20,000 $371,079 20,000 $142,200
2014-05 0 $0 20,197 $314,148 20,197 $138,416
2014-03 0 $0 61,934 $872,963 61,934 $475,827
2013-11 0 $0 42,872 $673,303 42,872 $173,618
2013-08 0 $0 11,375 $224,656 1,011,375 $11,098,189
2012-12 520 $208 100,520 $956,839 0 $0
2012-11 0 $0 625 $5,837 0 $0
2011-08 0 $0 0 $0 2,500 $1,000
2011-06 50,000 $356,675 0 $0 0 $0
2010-05 0 $0 0 $0 1,250 $500
2009-05 0 $0 37,500 $468,300 37,500 $256,500
2008-12 0 $0 12,000 $237,970 0 $0
2008-11 395,104 $4,999,992 0 $0 0 $0
2008-10 0 $0 0 $0 3,125 $1,250
2008-07 37,500 $256,500 0 $0 0 $0
2007-12 862,746 $10,912,433 0 $0 0 $0
2007-11 0 $0 0 $0 2,500 $1,000
2007-06 1,493,849 $17,000,001 0 $0 0 $0
2007-03 0 $0 0 $0 35,000 $14,000
2007-02 0 $0 0 $0 35,625 $304,500
2006-12 0 $0 0 $0 10,000 $2,000
2006-09 0 $0 0 $0 145,000 $58,000

Table 2. Detailed insider stock purchases, sales, and option exercises of Osiris Therapeutics, Inc. insiders (OSIR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-01-25 Dresner David A (Interim President & CEO) Option Ex 15,000 5.30 79,500
2017-01-23 Dresner David A (Interim President & CEO) Option Ex 5,000 5.03 25,150
2017-01-12 Dresner David A (Interim President & CEO) Option Ex 5,000 4.75 23,750
2015-11-20 Debrabandere Lode (President & CEO) Option Ex 37,500 6.84 256,500
2015-11-19 Danilkovitch Alla (Chief Scientific Officer) Option Ex 4,000 5.08 20,320
2015-08-10 Danilkovitch Alla (Chief Scientific Officer) Sale 2,425 18.22 44,183
2015-08-10 Danilkovitch Alla (Chief Scientific Officer) Option Ex 5,000 .40 2,000
2015-06-04 Law Gregory Ivan (Principal Accounting Officer) Buy 100 18.83 1,882
2015-05-27 Jacoby Philip R Jr (Chief Financial Officer) Sale 20,000 18.55 371,079
2015-05-27 Jacoby Philip R Jr (Chief Financial Officer) Option Ex 20,000 7.11 142,200
2014-05-29 Neumayer Matthew Paul (Principal Accounting Officer) Sale 500 15.55 7,775
2014-05-29 Neumayer Matthew Paul (Principal Accounting Officer) Option Ex 500 6.46 3,230
2014-05-27 Neumayer Matthew Paul (Principal Accounting Officer) Sale 3,750 16.10 60,375
2014-05-27 Neumayer Matthew Paul (Principal Accounting Officer) Option Ex 3,750 6.92 25,950
2014-05-21 Jacoby Philip R Jr (Chief Financial Officer) Sale 15,947 15.43 245,998
2014-05-21 Jacoby Philip R Jr (Chief Financial Officer) Option Ex 15,947 6.85 109,236
2014-03-14 Williams Michelle Leroux (Chief Scientific Officer) Sale 11,934 13.91 166,013
2014-03-14 Williams Michelle Leroux (Chief Scientific Officer) Option Ex 11,934 12.01 143,327
2014-03-13 Williams Michelle Leroux (Chief Scientific Officer) Sale 50,000 14.14 706,950
2014-03-13 Williams Michelle Leroux (Chief Scientific Officer) Option Ex 50,000 6.65 332,500
2013-11-25 Jacoby Philip R Jr (Chief Financial Officer) Sale 18,372 15.98 293,676
2013-11-25 Jacoby Philip R Jr (Chief Financial Officer) Option Ex 18,372 6.22 114,328
2013-11-15 Williams Michelle Leroux (Chief Scientific Officer) Sale 24,500 15.49 379,627
2013-11-15 Williams Michelle Leroux (Chief Scientific Officer) Option Ex 24,500 2.42 59,290
2013-08-20 Neumayer Matthew Paul (Principal Accounting Officer) Sale 11,375 19.75 224,656
2013-08-20 Neumayer Matthew Paul (Principal Accounting Officer) Option Ex 11,375 8.63 98,189
2013-08-14 Friedli Peter Option Ex 1,000,000 11.00 11,000,000
2012-12-11 Williams Michelle Leroux (Chief Scientific Officer) Buy 520 .40 208
2012-12-11 Williams Michelle Leroux (Chief Scientific Officer) Sale 520 9.31 4,839
2012-12-10 Venturetec Inc Sale 50,000 9.52 476,000
2012-12-10 Friedli Peter Sale 50,000 9.52 476,000
2012-11-15 Friedli Peter Sale 625 9.34 5,837
2011-08-15 Jacoby Philip R Jr (Chief Financial Officer) Option Ex 2,500 .40 1,000
2011-06-06 Barnhill Gregory Hurd Buy 25,000 7.07 176,700
2011-06-03 Barnhill Gregory Hurd Buy 25,000 7.20 179,975
2010-05-28 Jacoby Philip R Jr (Chief Financial Officer) Option Ex 1,250 .40 500
2009-05-14 Debrabandere Lode (Senior Vice President) Sale 37,500 12.49 468,300
2009-05-14 Debrabandere Lode (Senior Vice President) Option Ex 37,500 6.84 256,500
2008-12-08 Carmitchel Harry E (Chief Operating Officer) Sale 7,000 19.46 136,220
2008-12-03 Carmitchel Harry E (Chief Operating Officer) Sale 5,000 20.35 101,750
2008-11-14 Venturetec Inc Buy 189,681 13.18 2,499,995
2008-11-14 Friedli Peter Buy 205,423 12.17 2,499,997
2008-10-16 Jacoby Philip R Jr (Vice President of Finance) Option Ex 3,125 .40 1,250
2008-07-03 Fender Earl R Buy 37,500 6.84 256,500
2007-12-19 Venturetec Inc Buy 100,000 12.37 1,237,000
2007-12-19 Friedli Peter Buy 762,746 12.69 9,675,433
2007-11-21 Jacoby Philip R Jr (Interim Chief Financial Off.) Option Ex 2,500 .40 1,000
2007-06-06 Venturetec Inc Buy 263,620 11.38 2,999,995
2007-06-06 Friedli Peter Buy 1,230,229 11.38 14,000,006
2007-03-02 Claiborne Cary J (Chief Financial Officer) Option Ex 15,000 .40 6,000
2007-03-01 Carmitchel Harry E (Chief Operating Officer) Option Ex 20,000 .40 8,000
2007-02-28 Carmitchel Harry E (Chief Operating Officer) Option Ex 20,000 .40 8,000
2007-02-28 Jacoby Philip R Jr (Principal Accounting Officer) Option Ex 1,125 .40 450
2007-02-05 Gutzwiller Felix Option Ex 3,500 23.62 82,670
2007-02-05 Barnhill Gregory Hurd Option Ex 2,500 23.62 59,050
2007-02-05 Moyes Jay M Option Ex 1,500 23.62 35,430
2007-02-05 Friedli Peter Option Ex 5,000 23.62 118,100
2007-02-01 Jacoby Philip R Jr (Principal Accounting Officer) Option Ex 2,000 .40 800
2006-12-20 Carmitchel Harry E (Chief Operating Officer) Option Ex 10,000 .20 2,000
2006-09-27 Carmitchel Harry E (Chief Operating Officer) Option Ex 25,000 .40 10,000
2006-09-27 Claiborne Cary J (Chief Financial Officer) Option Ex 45,000 .40 18,000
2006-09-11 Carmitchel Harry E (Chief Operating Officer) Option Ex 50,000 .40 20,000

Insider trading activities including stock purchases, stock sales, and option exercises of OSIR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Osiris Therapeutics, Inc. (symbol OSIR, CIK number 1360886) see the Securities and Exchange Commission (SEC) website.